Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2528-2025

Brand Name: CELSITE Product Name: CELSITE BABYPORT SET PUR 4,5F IV USA Recall

Brand Name: CELSITE Product Name: CELSITE BABYPORT SET PUR 4,5F IV USA Model/Catalog Number: 5433742 Software Version: N/A Product Description: CELSITE BABYPORT SET PUR 4,5F IV USA Component: N/A

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: CELSITE Product Name: CELSITE BABYPORT SET PUR 4,5F IV USA. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2528-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 21, 2025
FDA report date
Sep 17, 2025
Quantity in commerce
58 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brand Name: CELSITE Product Name: CELSITE BABYPORT SET PUR 4,5F IV USA Model/Catalog Number: 5433742 Software Version: N/A Product Description: CELSITE BABYPORT SET PUR 4,5F IV USA Component: N/A

Affected model & UDI checker

Search the exact identifiers published for Z-2528-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
5433742Brand Name: CELSITE Product Name: CELSITE BABYPORT SET PUR 4,5F IV USACheck source noticeNot specified
FDA code information

Model/Catalog Number: 5433742; Primary-DI 04046963594947; Lot 37041185; Exp 19MAR2030;

View the original FDA recall notice

Why was this product recalled?

The potential for minor injury such as damage to the vessel and/or tearing of the vessel wall.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did B.Braun Medical S.A.S. take?

On July 21, 2025 URGENT - FIELD SAFETY NOTICE - PRODUCT RECALL letters were sent to customers. Actions to be taken: Check whether you have the above-mentioned product in stock, and quarantine it. Confirm the receipt of this Field Safety Notice on the enclosed confirmation form. Additionally record on the enclosed confirmation form the received amount of potentially affected products with the above-mentioned batch number(s) as well as the amount used and the amount to be returned. Even if you don't have any inventory, please return the completed and signed confirmation form in a timely manner to the fax number or e-mail address given on the form. Return the quarantined product to the following address with a copy of the enclosed confirmation form. Please retain this Field Safety Notice until you have completed all the above measures. Please make sure that all users of the above-mentioned products in your organization and other concerned persons are informed about this Field Safety Corrective Action. If you have forwarded the products to a third party, please forward a copy of the Field Safety Notice to them or inform the contact person provided. We sincerely apologize for any inconvenience this recall may cause. To compensate for the recalled product(s), a replacement or a credit note. Please contact our dedicated customer service team to arrange for compensation.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology